Skip to Content

Pluvictoᵀᴹ Treatment


Prostate cancer demands advanced solutions, especially when it spreads. ImageCare Radiology proudly introduces Pluvictoᵀᴹ, a targeted treatment revolutionizing prostate cancer treatment in New Jersey. As the sole independent outpatient center offering this advanced therapy, ImageCare Radiology combines expertise, diagnostic imaging technology, and a patient-centric approach to elevate your prostate cancer treatment experience.

Understanding Pluvictoᵀᴹ Prostate Cancer Treatment

Pluvictoᵀᴹ, powered by lutetium Lu 177 vipivotide tetraxetan, represents a breakthrough in prostate cancer management. This FDA-approved radioactive medicine specifically addresses cases where prostate cancer has spread, offering hope to those unresponsive to standard treatments for prostate cancer. While not a cure, Pluvictoᵀᴹ extends life expectancy and curtails tumor growth.

Why Choose ImageCare Radiology for Pluvictoᵀᴹ Treatment

  • Expertise and Innovation: ImageCare Radiology stands as the exclusive independent outpatient center delivering Pluvictoᵀᴹ treatment. With extensive experience in PSMA PET and a state-of-the-art Dual Ring PET Scanner, our commitment to innovation ensures that patients receive the latest in imaging, safety, and comfort for optimal outcomes.
  • Patient-Centric Care: Navigating prostate cancer can be complex, and ImageCare Radiology places your comfort and well-being at the forefront. Our team is dedicated to providing a seamless experience, from initial consultation to treatment completion, ensuring patients are informed, supported, and cared for throughout their journey.

Is Pluvictoᵀᴹ Right For You?

Pluvictoᵀᴹ may be suitable if you have:

  • Prostate cancer unresponsive to standard treatments
  • Prostate cancer that has metastasized
  • PSMA-positive prostate cancer

Before initiating treatment, a comprehensive assessment, including blood tests and a PSMA-PET scan, determines candidacy for Pluvictoᵀᴹ.

What To Expect During the Treatment Journey

  • Timeline:The Pluvictoᵀᴹ treatment spans approximately eight months, comprising six sessions every six weeks.
  • Day of Treatment:Each treatment involves a 1-hour infusion or IV administration in a private room. Monitoring follows for 15-30 minutes post-treatment, with safety instructions provided before departure.
  • Radiation Safety:During and post-infusion, safety precautions are observed, including restrictions on close interactions for a few days. Specific guidelines may vary, and individual safety measures are discussed with your physician.
  • Potential Side Effects: Post-treatment, common side effects may include fatigue, dry mouth, nausea, low red blood cell count, loss of appetite, and changes in bowel movements.

Initiating Your Pluvictoᵀᴹ Journey

A referral is required To explore Pluvictoᵀᴹ as a prostate cancer treatment option. Consult your doctor to determine suitability, or contact ImageCare Radiology at 973-810-8100 for more information. At ImageCare Radiology, we are committed to advancing prostate cancer care, one patient at a time. Your journey to renewed hope begins with Pluvictoᵀᴹ at ImageCare Radiology.